on April 27, 2026 at 3:14 pm Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal​P.R. Venkat

Sun Pharma has offered to pay $14 a share in an all-cash deal, putting the Indian drugmaker on track to become one of the top three global players in women’s health.